Market Tracker

09/23 5:16pm ET

Mateon Therapeutics Inc (NASDAQ:MATN)

0.59
Delayed Data
As of Sep 23
 +0.015 / +2.61%
Today’s Change
0.49
Today|||52-Week Range
1.33
-22.36%
Year-to-Date
No recent news for Mateon Therapeutics Inc.

Today’s Trading

Previous close0.57
Today’s open0.59
Day’s range0.58 - 0.60
Volume36,998
Average volume (3 months)361,106
Market cap$15.7M
Dividend yield--
Data as of 3:58pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+28.00%
Earnings growth (this year)-5.56%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
WGBSWaferGen Bio-systems...-0.02-2.45%
STEMStemCells Inc+0.03+2.14%
XTNTXtant Medical Holdin...-0.12-9.75%
DRIODarioHealth Corp+0.05+1.59%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$13.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
William D. Schwieterman
Chief Financial &
Accounting Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts